In separate reports on FDA's budget, House and Senate funding committees both say they are "significantly concerned" about FDA's progress to permit marketing of new sunscreen ingredients to be made available.
The Senate report points out that FDA has not approved an additional OTC sunscreen ingredient since implementation of the 2014 Sunscreen Innovation Act
The House and Senate passed separate bills setting FDA's fiscal 2019 direct appropriation from the US Treasury as well as user fee amounts. The House approved its bill in mid-July and the Senate approved its version of the bill on Aug. 1. Each bill is discussed in a report by the respective chambers' Appropriations Committee